NCT03399799
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03399799
Title Dose Escalation Study of JNJ-64407564 in Participants With Relapsed or Refractory Multiple Myeloma
Acronym MonumenTAL-1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | NLD | ESP | BEL

Facility Status City State Zip Country Details
University of Alabama Birmingham Birmingham Alabama 35294 United States Details
City of Hope Duarte California 91010 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Mount Sinai Medical Center New York New York 10029 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman Liège 4000 Belgium Details
VU Medisch Centrum Amsterdam 1081 HV Netherlands Details
UMCU Utrecht 3584 CX Netherlands Details
Hosp. Univ. Germans Trias I Pujol Badalona 08916 Spain Details
Hosp Univ Fund Jimenez Diaz Madrid 28040 Spain Details
Clinica Univ. de Navarra Pamplona 31008 Spain Details
Hosp. Quiron Madrid Pozuelo Pozuelo de Alarcón 28223 Spain Details
Hosp Clinico Univ de Salamanca Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field